Mar 16 2010
Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker
Code 8086) today announced the successful completion of a short-form
merger of Home Diagnostics, Inc. (NASDAQ: HDIX) with Nipro’s
wholly-owned subsidiary, Nippon Product Acquisition Corporation (the
“Purchaser”).
To complete the acquisition of 100% of Home Diagnostics’ shares, the
Purchaser has effected a short-form merger pursuant to Delaware law in
which the Purchaser has merged with and into Home Diagnostics, with Home
Diagnostics surviving the merger and continuing as a wholly-owned
subsidiary of Nipro. As a result of the merger, any Home Diagnostics
shares not tendered pursuant to the Purchaser’s previously-announced
tender offer (other than any (i) treasury shares, shares held by any
Home Diagnostics subsidiary or shares held by Nipro or any of its
subsidiaries and (ii) shares held by a holder who has not voted in favor
of or consented to the merger and who has properly demanded and
perfected the holder’s appraisal rights under Delaware law) will be
converted into the right to receive $11.50 in cash, without interest and
less any required withholding taxes.
Following the merger, Home Diagnostics’ shares will cease to be traded
on the Nasdaq Global Select Market.